It depends on why you're prescribed the drug and which plan you have. Semaglutide and similar GLP-1 medications are generally covered when prescribed for type 2 diabetes (as Ozempic or Mounjaro), but the same drug class prescribed specifically for weight loss (Wegovy, Zepbound) is a coin flip — some marketplace plans cover it, many exclude it outright, and almost all that do cover it require prior authorization first.
The single biggest factor in whether a GLP-1 drug is covered is the diagnosis code it's billed under, not the drug itself. Ozempic and Mounjaro are FDA-approved for type 2 diabetes, and diabetes medications are treated like any other chronic-condition prescription drug — most marketplace plans cover them on some tier of their formulary, typically with a copay or coinsurance.
Wegovy and Zepbound are the same class of drug (or close to it) but FDA-approved specifically for chronic weight management. Marketplace plans are not required to cover weight-loss drugs as an essential health benefit, so this is where formularies diverge sharply. Some plans cover it with strict prior authorization; a lot of plans exclude the whole drug class for a weight-loss indication, full stop.
Don't guess — check the formulary. Every marketplace plan publishes a drug list (sometimes called a formulary or covered-drug list) as a PDF or searchable tool on the carrier's site. Before enrolling:
If a specific weight-loss drug is non-negotiable for you, formulary-checking should happen before you pick a plan on quote-online, not after.
GLP-1 drugs are expensive — often several hundred dollars a month before insurance, more without it. Even on a plan that covers Wegovy or Zepbound, expect meaningful out-of-pocket cost until you clear your deductible, because specialty-tier drugs are rarely a flat low copay. A silver plan with cost-sharing reductions, if your income qualifies, generally lowers this bite more than switching carriers does — CSR plans reduce prescription cost-sharing across the board, not just office visits.
Manufacturer savings cards can offset cost further for commercially insured patients, but eligibility rules and caps vary and change; check the manufacturer's own current terms rather than relying on last year's numbers.
A few realistic paths if your current or prospective plan excludes weight-loss GLP-1s:
This is a coverage question, not a medical one — talk to your doctor about whether a GLP-1 is right for you at all; this article only covers what marketplace insurance does and doesn't pay for.
If a specific GLP-1 drug matters to your plan choice, treat the formulary the way you'd treat an in-network doctor check: verify it by name, by tier, and by prior-authorization requirement before you commit. Run your household numbers through the subsidy calculator first so you know your real budget for specialty-tier drug costs, then compare formularies across the plans you can actually afford. I check this for clients every open enrollment — it's a five-minute call, and it's free.
Generally yes, when prescribed for type 2 diabetes — it's treated as a standard chronic-condition medication on most formularies, usually with a copay or coinsurance depending on the plan's drug tier. Coverage still varies by carrier and plan, so confirm on the specific plan's formulary.
Sometimes. Wegovy is FDA-approved for weight management, which marketplace plans aren't required to cover. Some plans cover it with prior authorization (often requiring a BMI threshold or a related health condition); many plans exclude weight-loss GLP-1s from the formulary entirely. Check the specific plan's drug list before assuming either way.
No — prior authorization is a review step, not a guarantee. The plan reviews your doctor's documentation (diagnosis, BMI, prior treatment attempts) against its own criteria and can deny the request. Your doctor's office typically handles the submission and can appeal a denial.
Generally no — outside open enrollment, you need a qualifying life event to change marketplace plans. The special enrollment checker can tell you in about a minute whether a recent life change opens that window for you.
Traditional Medicare has historically excluded drugs used solely for weight loss, though coverage rules for this drug class have been shifting and can differ when a covered condition like diabetes or certain cardiovascular indications applies. If you're on Medicare, ask your plan directly about your specific drug and diagnosis rather than assuming marketplace rules apply — the programs are governed separately.
Older generic diabetes and weight-management medications are far more likely to be covered at a low copay than the newer GLP-1 brands, and manufacturer savings programs sometimes lower out-of-pocket cost for eligible patients. Talk to your doctor about what's clinically appropriate for you — this is a medical decision, not just a cost one.
Plans differ by carrier, county, and income. I'll check the actual 2026 plans where you live — free, in about 10 minutes, no pressure.
No cost. No pressure. No obligation to enroll.
Free tools and guides — no phone number required:
Important: This article is general information, not insurance, legal, tax, or medical advice. Coverage details vary by plan, carrier, state, and county, and change over time — always confirm benefits with the specific plan documents or a licensed agent before making decisions. Smooth Health Solutions is not connected with or endorsed by the U.S. government, the federal Medicare program, CMS, HealthCare.gov, or any state marketplace or government agency.